Background: This study evaluated the relationship between inflammation, intra-hepatic oxidative stress, oxidative DNA damage and the progression of liver carcinogenesis in hepatitis C virus (HCV)-infected humans.
Hepatocellular carcinoma (HCC) is one of the worldÕs most common cancers, causing almost one million deaths annually. 1 While risk factors for HCC are well-established and include liver cirrhosis due to alcohol and chronic viral infection (hepatitis virus B and C), aflatoxin B1 exposure and a variety of metabolic liver diseases, 2 the mechanisms that lead to this devastating disease are largely unknown. More than 90% of HCC in Japan is predominantly related to hepatitis C virus (HCV) infection. 3 Epidemiological and experimental studies suggest that HCV-associ-ated carcinogenesis in the liver is dependent upon prolonged viral infection, resulting in cell necrosis, liver cell renewal and chronic inflammation. 4 One strong mechanistic link between chronic inflammation and cancer is through the increased production of free radicals at the site of inflammation and the resulting molecular changes, which include lipid peroxidation and oxidative DNA damage. 5 Indeed, markers of DNA damage, such as 8-hydroxydeoxyguanosine , and lipid peroxidation, such as 4-hydroxynonenal (HNE) and malondialdehyde (MDA), are commonly elevated in liver of patients with chronic HCV infection and correlate well with the degree of viral infection and inflammation, known risk factors for HCC. 6 Improved surveillance and imaging techniques have led to earlier detection of HCC and an increased opportunity to treat patients; however, the prognosis for patients with HCC remains to be poor. 7 The recurrence of HCC is high, and it has been suggested that the degree of liver inflammation is associated to the length of patient disease-free survival. 8 While the results from several studies have suggested the value of markers of inflammation in predicting the survival of patients with HCC, including those who are HCVpositive, 9 little is known about the potential predictive power of oxidative stress markers.
In this study, we tested the hypothesis that the degree of oxidative DNA damage, inflammation and lipid peroxidation correlates with the prognosis of disease-free survival after resection of HCC in patients with HCV infection. Patients enrolled in our study who had undergone a surgical removal of the liver tumor were followed up with regular visits to an outpatient clinic. The duration of time before a new liver tumor was diagnosed by tumor markers and/or imaging examination, such as ultrasonography (USG), computed tomography (CT) or magnetic resonance imaging (MRI), i.e. disease-free survival, was recorded. One of our goals was to determine whether any of the available routine clinical markers retrieved from a patientÕs records or any of the markers of oxidative stress and inflammation that were measured in this study correlated with the length of disease-free survival and thus potentially assist in clinical prognosis. By evaluating the relationship between inflammation, intra-hepatic oxidative stress, oxidative DNA damage and the progression of carcinogenesis in HCV-infected human liver we were able to show that patients with greater intra-hepatic oxidative stress exhibited a much faster recurrence of HCC. We therefore suggest that the measurement of oxidative stress biomarkers in tumor-free liver parenchyma removed at the surgical margin around the tumor can be a potentially useful clinical diagnostic tool to predict the length of disease-free survival in patients with HCV-associated HCC.
PATIENTS AND METHODS

Patients
Thirty patients with solitary HCC diagnosed as having no vascular invasion were enrolled in this study and underwent complete removal of the tumor at the University of Yamanashi Hospital (Yamanashi Prefecture, Japan) between July 1994 and December 2001. All of the patients tested positive for HCV and negative for HBV (data not shown). The presence and identification of the hepatitis virus was determined by one or more of the following techniques: (1) presence of anti-HCV and anti-HBV reactive serum proteins, (2) reverse transcription-PCR for serum HCV-RNA or (3) branched DNA-HCV probe assay. Following the liver resection patients returned to the ambulatory care clinic for additional tests monthly. Serum a-fetoprotein levels were measured every month. In addition, USG and CT of the liver were performed every 3 and 6 months, respectively. Six patients who were HCV/HBV-free but were diagnosed with metastatic liver tumors that required liver resection of the tumor mass were enrolled as the control group. Informed consent was obtained from all subjects who participated in the study, and the study was approved by the Institutional Board on Ethics for Human Science at the University of Yamanashi. All available clinical data for the patients enrolled in this study are summarized in Table 1 .
Tissues
Sections of tumor-free liver parenchyma from the surgical margin removed during tumor resection were collected at the time of the operation. Tissues were fixed in formalin (10%), dehydrated in absolute ethanol and embedded in paraffin. Serial sections (5 lm thick) were prepared at the University of Yamanashi and sent to the University of North Carolina for further immunohistochemical analysis.
Immunohistochemical Detection of CD68, 8-OHdG, HNE and Apurinic/Apyrimidinic Endonuclease 1 (APE)
Paraffin-embedded serial sections of liver tissues were stained immunohistochemically with anti-CD68 (PG-M1, DAKO, Kyoto, Japan), anti8OHdG (N45.1; Jaica, Shizuoka, Japan), anti-HNE (HNE11S; Alpha Diagnostics, San Antonio, Tex.) or anti-APE1/Ref-1 (NB100-116; Nubous Biologicals, Littleton, Colo.) antibodies. Immunohistochemical staining was performed on paraffin-embedded sections. Briefly, after deparaffinization and rehydration, the antigen retrieval procedure was applied (for CD68 and 8-OHdG staining) by heating the slides in .1 M citrate buffer (pH 6.0) for 10 min. The sections were then incubated first with .3% H 2 O 2 in distilled water for 5 min to block endogenous peroxidase and then incubated with one of the following antibodies: monoclonal mouse antihuman CD68 for 30 min, HNE (diluted to 1:200) for 10 min, 8-OHdG (10 mg/ml) at 4°C overnight or APE (diluted to 1:200) for 60 min. Biotinylated secondary antibody conjugated with avidin-biotinhorseradish peroxidase (Dako Envison kit/HRP; Dako, Kyoto, Japan) and 3¢,3¢-diaminobenzidine tetrahydrochloride were used for standard avidinbiotinylated peroxidase detection. Cells that stained positive for CD68 and APE were counted in ten different random fields at a magnification of 400·. The hepatocytes that stained positively for 8-OHdG were counted (at least 1000 cells in each slide), and the percentage of positive cells was calculated. Quantitation of HNE-protein adducts was performed using image analysis software (Scion Image; Scion Corp., Frederick, M.D.) by evaluating five different fields (magnification: 100·) for areas positively stained for HNE-protein adducts and expressed as a percentage of total area.
Statistics
The STATVIEW software (ver. 5.0, SAS institute Cary, N.C) was used for statistical analysis. For the univariate analysis, two-sample t-test, linear regression or Logrank test statistical procedures were used to assess which endpoints could be used for predicting the prognosis of HCC patients after surgery. For the multivariate analysis, the Cox proportional hazard model was used to calculate hazard ratio and the P value of each parameter. A P value of less than .05 was considered to be significant.
RESULTS
Markers of Oxidative Stress and Inflammation
Accumulate in the liver of Patients with HCVAssociated HCC Hepatocellular carcinoma and viral hepatitis are known to produce a state of chronic oxidative stress in the liver that is thought to be associated with chronic inflammation. This study investigated whether mechanism-based molecular markers of oxidative stress and inflammatory response are useful endpoints that can be easily evaluated in specimens collected during liver tumor resection in (1) patients with solitary tumors in the liver that were a result of metastasis from other organs and (2) subjects manifesting HCC in combination with chronic HCV infection and the absence of known tumors at other sites (Fig. 1) . With the exception of the indocyanine green (ICG) clearance test result, there was no significant difference in the clinical characteristics of these two groups of patients in this study when traditional clinical parameters were considered (Table 1) . Consequently, additional experiments were performed using liver parenchymal tissue that appeared to be tumor-free but which was excised during tumor resection as a ''surgical margin''. We assumed that these samples of the margin tissue were an accurate representation of the remaining ''normal'' liver parenchyma in each patient.
Immunohistochemical detection of 8-OHdG, a marker of oxidative DNA damage ( Fig. 2A) , HNE, a marker of lipid peroxidation (Fig. 2B ) and CD68, a marker of inflammatory cells such as macrophages and neutrophils (Fig. 2C) , was performed as described in the Patients and Methods section.
Positive staining for CD68, HNE and 8-OHdG was detected in both the patients with HCC and patients with metastatic liver tumors (MLT); however, the number of positively stained cells or the area of the positive staining was consistently significantly higher (CD68: P < .001, HNE: P < .005, 8-OHdG: P < .01) in patients with HCC (n = 30) than in patients with metastatic liver tumors (n = 6). We next evaluated the relationship between markers of inflammation, intra-hepatic oxidative stress and oxidative DNA damage in patients with HCV-associated HCC (Fig. 2D, E) . Interestingly, a strong positive correlation was observed between these three measures of the pathophysiological processes occurring in the liver of these patients.
When patients with HCV-associated HCC were sub-divided into two groups (''low'' and ''high'') based on the median value of each of the three markers evaluated in this study (CD68, HNE and 8-OHdG), 12 out of 15 patients were classified as ''high'' for all three markers and two were classified as ''high'' for two out of the three (data not shown). Furthermore, when clinical characteristics were compared between ''low'' and ''high'' patients for each marker, no significant differences were observed (Table 1) , with the exception of the results of the ICG retention test (n = 24, P = .018). The latter was also significantly higher in patients who exhibited a greater inflammatory response (as determined by the number of CD68-positive cells in the liver; n = 11, P = .023) but lower in patients with high lipid peroxidation marker accumulation (HNE-positive staining; n = 13, P=.016). While several studies have linked chronic liver inflammation with an increase in organ dysfunction as measured by ICG clearance, 10,11 the significance of the observed negative association between lipid peroxidation and organic anion transport in liver is uncertain.
Markers of Oxidative Stress and Inflammation Improve Prediction for the Length of Disease-Free Survival in Patients with HCV-Associated HCC
The univariate analysis of the prognostic power for various measurements taken in this study showed that none of the routinely collected indices of tumor progression were able to achieve statistical   FIG. 1 . Working hypothesis. We hypothesized that mechanismbased molecular markers of oxidative stress and inflammatory response would be useful for predicting disease-free survival after liver tumor resection in subjects manifesting hepatocellular carcinoma (HCC) in combination with chronic hepatitis C virus (HCV) infection and absence of known tumors at other sites.
significance in predicting the length of disease-free survival in patients with HCV-associated HCC (Table 2) . Interestingly, all three markers of oxidative stress and inflammation were significant (see Table 2 for group size and P values) in this analysis with the number of 8-OHdG-positive hepatocytes in the tumor-free surrounding parenchyma collected at the time of tumor removal being the most important. Figure 3 shows that when disease-free survival was plotted using the Kaplan-Meier method for all patients (solid lines) or by sub-dividing them into two groups (''high'' vs. ''low'') based on the median value for each of the markers (dashed and dotted lines, respectively), there was a dramatic significant difference (see Table 2 for group size and P values) in the clinical outcome between the groups. Importantly, the disease-free survival was significantly shorter in patients with strong staining for CD68, HNE and 8-OHdG, while there was no difference between these groups when traditional clinical parameters were compared ( Table 1) .
Expression of DNA Repair Protein APE Is Elevated in HCV-Associated HCC but Does Not Correlate with Disease-Free Survival
Chronic oxidative stress in liver not only increases DNA damage but also can lead to persistent upregulation of DNA repair genes. 12 It has been hypothesized that such an adaptive response may in fact be contributing to carcinogenesis. 13 Interestingly, in patients with ulcerative colitis (UC) the level of DNA repair protein APE has been found to be significantly higher in UC colon epithelium undergoing elevated inflammation and to be positively correlated with microsatellite instability.
14 In the present study, immunohistochemical staining for APE was performed on non-cancerous liver tissues from patients with liver tumors, as described in the Patients and Methods section. Although positive staining for APE was detected in both groups of patients, the area of positive staining was significantly (n = 30, P = .037) greater in patients with HCV-associated HCC than in patients with metastatic liver tumors (Fig. 4A) . APE protein level in livers of patients with HCC correlated with neither the degree of oxidative DNA damage (as measured by 8-OHdG-positive hepatocytes, Fig. 4B) , lipid peroxidation or the number of inflammatory cells (data not shown); nor did it show statistically significant predicting power in the univariate analysis of disease-free survival (Table 2) .
To further determine if an imbalance between oxidative DNA damage (8-OHdG) and DNA repair (APE) exists in patients with HCV-associated HCC and has an adverse effect on disease-free survival, the patients were categorized into five groups using the regression tree-based classification method 15 to maximize the difference between the groups (Fig. 5) . While the resulting chi-square statistic has a value of 20.4 (4 df, with a P value = .000421), indicating that the groups are significantly different, no significant improvement in predictive power was observed when APE was included in the analysis (dashed and dashed-and-dotted lines).
FIG. 2.
Immunohistochemical analysis for 8-hydroxydeoxyguanosine (8-OHdG), 4-hydroxynonenal (HNE) and CD68-positive cells in non-cancerous liver tissue from patients with HCV-associated HCC or metastatic liver tumors (MLT). Immunohistochemical staining for 8-OHdG (A), HNE (B) and CD68 (C) was performed in non-cancerous liver tissue collected from patients as described in detail in the Patients and Methods section. The boxes and error bars indicate the 25-75th percentile and the 10-90th percentile, respectively. Statistical significance is indicated with asterisks (*P < .01; **P < .005; and ***P < .001) as compared to the data in MLT patients. Panels D and E show correlations between markers assessed in this study in each of the patients with HCV-associated HCC.
Multivariate Analysis of Disease-Free Survival Outcome in Patients with HCV-Associated HCC Shows the Utility of Additional Novel Molecular Markers of Oxidative Stress and Inflammation
In general, the size and stage of the tumor, serum alanine aminotransferase (ALT) level and serum alpha-fetoprotein (AFP) concentration are thought to be useful in assessing the potential for a relapse of HCC after complete tumor resection. In our study, the univariate analysis failed to show that such clinical parameters alone can serve as significant predictors for the recurrence of the disease. To evaluate the effect of novel molecular markers of oxidative stress and inflammation on the predictive power of traditional clinical parameters, we included the percentage of 8-OHdG-positive hepatocytes, size of the tumor, stage of the tumor, ALT and AFP all together in the multivariate analysis. The result from the Cox proportional hazard analysis showed that the percentage of 8-OHdG-positive hepatocytes, the size and stage of the tumor, serum ALT level and serum AFP concentration appear to be independent risk factors for the relapse of HCC (Table 3) . Although the hazard ratio of the percentage of 8-OHdG-positive hepatocytes was 1.174 (95% C.I. 1.089-1.266), the association with the disease outcome was the strongest among all other endpoints (P < .0001), suggesting that the percentage of 8-OHdG-positive cells in non-cancerous liver parenchyma is a good predictor of a relapse of HCC.
Since the CD68 and HNE markers were found to be co-linear with 8-OHdG, it is not surprising that they also were found to be strong predictors of disease-free survival in this patient cohort. When either of these two markers was included into the multivariate analysis in place of 8-OHdG, they were found to be the only significant predictors with HNE having a hazard ratio of 1.243 (95% C.I. 1.106-1.397, P < .0003) and CD68 with a hazard ratio of 1.072 (95% C.I. 1.027-1.119, P < .0015).
DISCUSSION
The hepatitis C virus is a significant cause of disease-associated morbidity and mortality worldwide. 16 Chronic viral infection of the liver leads to hepatocellular necrosis, inflammation and liver regeneration, all of which are associated with the infiltration of immune cells that produce reactive oxygen and nitrogen species. 17 In addition, HCV core protein overexpression in mice has been shown to contribute to hepatic oxidative stress through mitochondrial dysfunction. 18, 19 Oxygen free radical-induced DNA damage as well as the adaptive imbalance in DNA repair lead to the accumulation of missense mutations in cancer-related genes and microsatellite instability, and have been strongly implicated as primary causes of human cancers that are a result of chronic inflammation.
5,15
The disease-free survival rate is a common clinically useful parameter that determines the outcome of the treatment of HCC. After tumor resection, which is the choice of treatment for HCC in non-cirrhotic patients, the tumor recurrence rate exceeds 70% at the 5-year follow-up. [20] [21] [22] Many pathological features, such as tumor size, number of tumors in the liver, capsule state, cell differentiation, venous invasion and the extent of intra-hepatic spreading, are commonly used in clinical diagnosis as predictive risk Patients with HCV-associated HCC were divided into two groups based on the median of the distribution of each variable [total number of patients (n) in each group is shown]. Data shown are the mean ± SD for each variable (with the exception of TMN classification and tumor differentiation), or the number of patients in each group for tumor stage and differentiation. For each variable a cumulative survival rate for patients in each of the two groups was then calculated using the Kaplan-Meier method, and the P value for the difference between patients between groups was calculated using the Mantel-Cox logrank test. Bold highlights statistically significant data.
factors for HCC recurrence and health prognosis in patients. Overall, the most powerful predictors of recurrence are the presence of microvascular invasion and additional tumor sites. [20] [21] [22] The recurrence of HCC is thought to occur primarily due to dissemination and the de novo formation of tumors. 23 The latter is thought to be due to the same predisposition factors as those that lead to the formation of a primary tumor. Thus, an assessment of the state of the tumor-free liver parenchyma at the time of resection of the primary carcinoma may yield important clues regarding the relative importance of the factors that promote carcinogenesis in liver, such as oxidative stress to DNA. The present study examined a series of molecular markers of inflammation, oxidative stress and DNA damage in non-cancerous liver tissue from patients undergoing tumor resection with the objective of gaining an understanding of the extent of the molecular changes in remaining liver parenchyma and their potential value in predicting the outcome of the treatment by surgical resection.
The molecular profiling of HCC and mechanismbased markers are expected to refine the assessment of recurrence and disease outcome. Many gene expression profiling studies have been performed to date in attempts to correlate changes in mRNA levels with disease-free survival in patients with HCVassociated HCC. [24] [25] [26] ; however, none of the proposed markers have yet to gain wide-spread acceptance or to become routine in clinical practice. 27 Still, while it was suggested that marked inflammatory cell infiltration in the tumor could provide a better prognosis of disease-free survival, 22 subsequent microarray studies have confirmed that an expression signature characteristic of activated lymphocytes infiltrating the cirrhotic liver and activated liver macrophages can be detected in tumors of patients with HCV. 26 Our study shows that immunohistochemical detection of CD68-positive inflammatory cells in non-tumor parenchyma may be a useful predictor of disease-free survival. We suggest that the strong correlation between CD68-positive inflammatory cells and both markers of oxidative stress (HNE and 8-OHdG) as well as shorter disease-free survival observed in this study in patients with HCC supports the theory that CD68-positive inflammatory cells in the liver may be a key source for reactive intermediates that exacerbate liver injury and lead to cancer. Thus, chronic inflammation in the liver should be one of the prime targets for therapeutic intervention to prevent relapse of HCC. Based on these observations, we have initiated a prospective human study that is evaluating the effect of anti-inflammatory therapy on disease-free survival in patients with HCV-associated HCC who underwent surgical removal of liver tumors.
While there are numerous reports of oxidative stress to DNA in hepatocellular carcinoma, 28, 29 little is known about the prognostic value of oxidative DNA damage. One recent study found that a high 8-OHdG labeling index in non-cancerous liver tissue may be a potentially useful prognostic marker for the recurrence of HCC, while a multivariate analysis revealed that tumor grade and stage were not found to be significant predictors. 9 Our study confirms this previous report in a different patient cohort and shows that the 8-OHdG labeling index is indeed a very good prognostic marker. Furthermore, we show here that accumulation of lipid peroxidation-modified proteins (HNE staining) in the liver is also a good independent predictor of disease-free survival. These findings strengthen the usefulness of these novel predictors.
It was reported recently that adaptive overexpression of base excision repair enzymes, the primary pathway that repairs oxidative DNA lesions, was observed in another tumor that depends on chronic inflammation, ulcerative colitis. 14 This study, along with others, 13, 30 presents convincing evidence that an imbalanced induction of DNA repair results in mutations and contributes to the progression of carcinogenesis. In our study, the protein expression of APE, a critical enzyme in the base excision DNA repair pathway, was increased in livers of HCV-infected patients with HCC. However, the level of APE expression did not correlate with disease-free survival. Furthermore, we did not detect a statistical relationship with shortened disease-free survival after resection of the primary tumor even in patients with strong discordant expression of APE and oxidative stress, DNA damage and inflammatory cell infiltration. The reasons for this lack of correlation between repair, DNA damage and recurrence of liver tumors are not clear and may be a factor of the small size of the patient population in this study.
In conclusion, the molecular markers selected in this study based on the pathogenesis of the disease strongly correlate with each other and are able to serve as independent strong predictors of disease-free survival in patients with HCV-associated HCC. Furthermore, we argue that a panel of mechanismbased molecular markers, rather than a single measure of oxidative stress and/or inflammatory response, should be used to increase precision and improve confidence in the post-operative prognosis.
